Physician profile
Hideki Ichino
NPI 1033136932
$4,599.82
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,752 · 2020: $288 · 2021: $436 · 2022: $419 · 2023: $509 · 2024: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,541.05 | 2019-2024 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $707.99 | 2019-2023 | Mitraclip |
| Medtronic Vascular, INC. | $361.66 | 2019-2020 | |
| Boston Scientific Corporation | $262.04 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor, Resonate El Icd Vr |
| Abiomed | $195.45 | 2020-2023 | Impella |
| Angiodynamics, INC. | $187.08 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.36 | 2024 | Jardiance |
| Siemens Medical Solutions USA, INC. | $74.16 | 2023 | Acuson Sc2000 Diagnostic Ultrasound System |
| Janssen Pharmaceuticals, INC | $50.94 | 2019-2023 | Xarelto |
| Terumo Medical Corporation | $44.62 | 2019 | |
| Heartflow, INC. | $30.47 | 2022 | |
| Novartis Pharmaceuticals Corporation | $28.57 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $22.98 | 2023 | Inpefa |
| Amgen INC. | $16.45 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hideki Ichino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.